Bortezomib in previously treated phosphatase and tension homology‐deficient patients with advanced intrahepatic cholangiocarcinoma: An open‐label, prospective and single‐centre phase II trialTianmei Zeng, Zhen-Gang Yuan|Clinical and Translational Medicine|2024Cited by 5